Content and data provided by various third parties and Fidelity − Terms of Use

Stock Details

RELATED RESOURCES
Print Format
Change Text Size:

BRIEF-Regulus Therapeutics Reports Q3 Net Loss $0.04 Per Share

BY Reuters
— 5:38 PM ET 11/05/2020

Nov 5 (Reuters) - Regulus Therapeutics Inc (RGLS):

* REGULUS THERAPEUTICS REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS AND RECENT UPDATES

* REGULUS THERAPEUTICS INC (RGLS) - QTRLY NET LOSS $0.04 PER SHARE

* REGULUS THERAPEUTICS INC (RGLS) - QTRLY REVENUE UNDER STRATEGIC ALLIANCES $5 MILLION VERSUS $18,000

* REGULUS THERAPEUTICS INC (RGLS) - AS OF SEPTEMBER 30, 2020, REGULUS HAD $17.8 MILLION IN CASH AND CASH EQUIVALENTS Source text for Eikon: Further company coverage:

Copyright © Reuters 2008. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.

More RGLS News
Copyright 1998–2021 FMR LLC. 
All rights reserved. 
Close